Blood filtration in a flash
A team of German researchers claim to have developed a new type of filter that clears blood faster than conventional methods by taking two steps at once.
BioMedNet, News, 26.
August 2003
BMN260803 - Sepsis is a serious problem in
hospitals worldwide, and the risk of infection is highest
in intensive care units, where patients are most
vulnerable. If sepsis occurs, blood has to be cleared of
pathogens as fast as possible, a process that normally
involves two steps.
First, plasma has to be separated from blood cells
(erythrocytes, leukocytes and platelets). Only then can
plasma be cleared of endotoxin, which may include fragments
of bacteria such as pathogenic Escherichia coli,
Pseudomonas aeruginosa, or Staphylococcus aureus, all
capable of triggering inflammatory reactions.
The two-step clean-up procedure involves a large amount of
apparatus and takes vital time. There is also an
alternative method, where blood is passed over an endotoxin
binding surface without separating plasma from blood cells.
It is faster, but the endotoxin-binding constituents on the
surface activate thrombocytes. Thus this method is not well
accepted.
Now, claim German researchers, a method has been developed
that takes the two steps in one, and should be well
accepted. For this method, blood streams through a bundle
of tiny hollow fibers, 360 micrometres in diameter.
Everything takes place in that bundle. Plasma and endotoxin
is separated from the blood cells in one step. "For this we
use hollow fibers which have tiny pores all around, one to
five micrometres in diameter," says Christian Oehr, chemist
at Fraunhofer Institute for Interfacial Engineering and
Biotechnology in Stuttgart.
The pores are big enough to allow plasma and endotoxin
constitutents to pass through, but too small for blood
cells. The fibers are composed of a common synthetic
material used in several other types of filter. "The pores
originate through the drying process, similar to the holes
in Swiss cheese," Oehr explained. The pores turn each fiber
into a filter.
For the second step, removing the endotoxin protein
fragments from the plasma, Oehr and his colleagues coat the
fiber with a layer of endotoxin binding molecules,
including oligo-arginine, which acts as an anchor for toxin
molecules. "Iteþs important that the fiber is not coated
inside, because than it would cause plugging," said Oehr.
In addition, thrombocytes would be activated again.
Early tests with artificial fluids and donated blood have
proved successful. "Next, we start clinical trials," said
Markus Storr, project manager at the company where the
filter is being developed - Gambro in Hechingen, near
Stuttgart. Storr will present the new filter to a broader
audience at the European Society of Artificial Organs
annual meeting, in Aachen, Germany, in September.
Besides clearing blood following sepsis, Storr predicts
that the filter could also be used for dialysis. "Dialysis
works through a simple size-dependent filter, which works
because it lets past uremic toxins, which are small
enough," he said. Storr and Oehr hope to use their new
nanofilter to clear blood not just faster but also, in some
cases, better. But, they warn, "First we have to take the
hurdle of the clinical trials, then we will see."
BioMedNet, News, 26.
August 2003
zurück zu: Die Texte 2003